Cargando…
The Lack of Systemic and Subclinical Side Effects of Botulinum Neurotoxin Type-A in Patients Affected by Post-Stroke Spasticity: A Longitudinal Cohort Study
Botulinum Neurotoxin type-A (BoNT-A) is the treatment of choice for focal post-stroke spasticity (PSS). Due to its mechanism of action and the administration method, some authors raised concern about its possible systemic diffusion leading to contralateral muscle weakness and autonomic nervous syste...
Autores principales: | Battaglia, Marco, Borg, Margherita Beatrice, Torgano, Lara, Loro, Alberto, Cosenza, Lucia, Bertoni, Michele, Picelli, Alessandro, Santamato, Andrea, Invernizzi, Marco, Uberti, Francesca, Molinari, Claudio, Carda, Stefano, Baricich, Alessio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414297/ https://www.ncbi.nlm.nih.gov/pubmed/36006227 http://dx.doi.org/10.3390/toxins14080564 |
Ejemplares similares
-
Triceps Surae Muscle Characteristics in Spastic Hemiparetic Stroke Survivors Treated with Botulinum Toxin Type A: Clinical Implications from Ultrasonographic Evaluation
por: Battaglia, Marco, et al.
Publicado: (2021) -
Rectus Femoris Characteristics in Post Stroke Spasticity: Clinical Implications from Ultrasonographic Evaluation
por: Cosenza, Lucia, et al.
Publicado: (2020) -
Ergonomic Recommendations in Ultrasound-Guided Botulinum Neurotoxin Chemodenervation for Spasticity: An International Expert Group Opinion
por: Lagnau, Philippe, et al.
Publicado: (2021) -
Adjunctive treatment and BoNT-A for post-stroke spasticity: Are we really focusing on the patient-centered goals?
por: Baricich, Alessio, et al.
Publicado: (2023) -
Early Botulinum Toxin Type A Injection for Post-Stroke Spasticity: A Longitudinal Cohort Study
por: Picelli, Alessandro, et al.
Publicado: (2021)